TREATMENT FOR STROKE IN THE EMERGENCY ROOM

Cerevast Therapeutics is developing a revolutionary treatment for acute ischemic stroke using a combination therapy, known as sonothrombolyis, or SonoLysis for short. This treatment consists of microspheres used in conjunction with approved lytics and a unique Hands-Free Transcranial Doppler (HF-TCD) ultrasound device.

Founded in 2009 and headquartered in Redmond, Washington, Cerevast will provide emergency room practitioners with the tools they need to treat this devastating disease.

NEWS

Cerevast Therapeutics is working with the stroke centers at the University of Texas at Houston and the University of Alabama at Birmingham on a key sonolysis safety trial.

Combined Lysis of Thrombus in Brain Ischemia With Transcranial Ultrasound and Systemic T-PA- Hands-Free (CLOTBUST HF) is an NIH funded Phase I/II Pilot Safety Trial.